1. Rab8a Is a Key Target That Melatonin Prevents Lipid Disorder from Atrazine.
- Author
-
Yang TN, Wang YX, Jian PA, Ma XY, Ren YF, Huang NN, Li XN, and Li JL
- Subjects
- Animals, Mice, Male, Mice, Inbred C57BL, Lipid Metabolism Disorders metabolism, Lipid Metabolism Disorders drug therapy, Lipid Metabolism Disorders genetics, Lipid Metabolism Disorders prevention & control, Lipid Metabolism Disorders chemically induced, Liver metabolism, Liver drug effects, Humans, Cell Line, rab GTP-Binding Proteins metabolism, rab GTP-Binding Proteins genetics, Atrazine toxicity, Lipid Metabolism drug effects, Hepatocytes drug effects, Hepatocytes metabolism, Melatonin pharmacology, Herbicides pharmacology, Mitochondria metabolism, Mitochondria drug effects
- Abstract
Atrazine (ATZ), a widely used herbicide, disrupts mitochondrial function and lipid metabolism in the liver. Melatonin (MLT), a naturally synthesized hormone, combats mitochondrial dysfunction and alleviates lipid toxicity. However, the mechanisms behind ATZ-induced lipid metabolism toxicity and the protective effects of MLT remain unexplored. Mice were randomly assigned to four groups: control (Con), 5 mg/kg MLT, 170 mg/kg ATZ, and a cotreatment group receiving 170 mg/kg ATZ with 5 mg/kg MLT (ATZ+MLT). Additionally, we analyzed the effects of MLT and Rab8a on mRNA and proteins related to mitochondrial function and lipid metabolism disrupted by ATZ in AML12 cells. In conclusion, ATZ induced mitochondrial stress and disrupted fatty acid metabolism in mouse hepatocytes and AML12 cells. Exogenous MLT restores Rab8a levels, regulating fatty acid utilization in mitochondria and mitochondrial function. Notably, targeting Rab8a does not significantly affect mitochondrial function but prevents ATZ-induced lipid metabolism disorders in hepatocytes.
- Published
- 2024
- Full Text
- View/download PDF